Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | C3 CL E G H | 718 | 1318 | OMIM:613779 | Complement component 3 deficiency, autosomal recessive | . | | | 92 | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | C3 CL E G H | 718 | 1318 | OMIM:612925 | Hemolytic uremic syndrome, atypical, susceptibility to, 5 | | | | 92 | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | CD46 CL E G H | 4179 | 6953 | OMIM:612922 | Hemolytic uremic syndrome, atypical, susceptibility to, 2 | | | | 39 | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | CFH CL E G H | 3075 | 4883 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | 86 | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | CFHR1 CL E G H | 3078 | 4888 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | CFHR3 CL E G H | 10878 | 16980 | OMIM:235400 | Hemolytic uremic syndrome, atypical, susceptibility to, 1 | . | | | | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | CFI CL E G H | 3426 | 5394 | OMIM:610984 | Complement factor I deficiency | . | | | 57 | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | CFI CL E G H | 3426 | 5394 | OMIM:612923 | Hemolytic uremic syndrome, atypical, susceptibility to, 3 | | | | 57 | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | DNASE1L3 CL E G H | 1776 | 2959 | OMIM:614420 | Systemic lupus erythematosus 16 | | | | 3 | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | IRAK1 CL E G H | 3654 | 6112 | ORPHA:93552 | Pediatric systemic lupus erythematosus | HP:0040281 - Very frequent | | | | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | LMNB2 CL E G H | 84823 | 6638 | ORPHA:79087 | Acquired partial lipodystrophy | HP:0040282 - Frequent | | | 11 | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | LMNB2 CL E G H | 84823 | 6638 | OMIM:608709 | Lipodystrophy, partial, acquired, susceptibility to | . | | | 11 | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | PACS1 CL E G H | 55690 | 30032 | ORPHA:329224 | Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome | HP:0040283 - Occasional | | | 24 | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | PRKCD CL E G H | 5580 | 9399 | OMIM:615559 | AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3 | | | | 10 | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | SPP1 CL E G H | 6696 | 11255 | ORPHA:93552 | Pediatric systemic lupus erythematosus | HP:0040281 - Very frequent | | | | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | STAT4 CL E G H | 6775 | 11365 | ORPHA:93552 | Pediatric systemic lupus erythematosus | HP:0040281 - Very frequent | | | 2 | | |
HP:0005421 | HP:0005421 | Decreased serum complement C3 | 0 | TLR7 CL E G H | 51284 | 15631 | OMIM:301080 | | | | | | | |